Published in Int J Nanomedicine on January 01, 2008
Putative nanobacteria represent physiological remnants and culture by-products of normal calcium homeostasis. PLoS One (2009) 1.17
The role of calcifying nanoparticles in biology and medicine. Int J Nanomedicine (2012) 0.91
Characterization of biofilm formed by human-derived nanoparticles. Nanomedicine (Lond) (2009) 0.90
Calcifying nanoparticles associated encrusted urinary bladder cystitis. Int J Nanomedicine (2008) 0.83
Cytotoxicity and apoptosis induced by nanobacteria in human breast cancer cells. Int J Nanomedicine (2013) 0.82
Clinical implications of calcifying nanoparticles in dental diseases: a critical review. Int J Nanomedicine (2013) 0.81
Cytotoxicity induced by nanobacteria and nanohydroxyapatites in human choriocarcinoma cells. Nanoscale Res Lett (2014) 0.76
Apoptosis-mediated endothelial toxicity but not direct calcification or functional changes in anti-calcification proteins defines pathogenic effects of calcium phosphate bions. Sci Rep (2016) 0.75
Nanobacteria in the pathogenesis of urolithiasis: Myth or reality? Indian J Urol (2015) 0.75
Toxic potential of materials at the nanolevel. Science (2006) 19.24
Renal clearance of quantum dots. Nat Biotechnol (2007) 12.54
Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc Natl Acad Sci U S A (1998) 2.68
An alternative interpretation of nanobacteria-induced biomineralization. Proc Natl Acad Sci U S A (2000) 1.87
Evidence of nanobacterial-like structures in calcified human arteries and cardiac valves. Am J Physiol Heart Circ Physiol (2004) 1.55
Alternatives to binary fission in bacteria. Nat Rev Microbiol (2005) 1.33
Cell biology of pathologic renal calcification: contribution of crystal transcytosis, cell-mediated calcification, and nanoparticles. J Investig Med (2006) 1.29
Nanobacteria--propagating calcifying nanoparticles. Lett Appl Microbiol (2006) 1.25
Nanomedicine: techniques, potentials, and ethical implications. J Biomed Biotechnol (2006) 1.20
The effects of serum and human albumin on calcium hydroxyapatite crystal growth. Biochem J (1990) 1.18
Nanobacteria: fact or fiction? Characteristics, detection, and medical importance of novel self-replicating, calcifying nanoparticles. J Investig Med (2006) 1.18
Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method. Antimicrob Agents Chemother (2002) 1.12
Nanotechnology, nanomedicine and nanosurgery. Int J Surg (2005) 1.11
An animal model of black pigment gallstones caused by nanobacteria. Dig Dis Sci (2006) 1.09
Nanobacteria: controversial pathogens in nephrolithiasis and polycystic kidney disease. Curr Opin Nephrol Hypertens (2001) 1.08
Detection of nanobacteria-like particles in human atherosclerotic plaques. Acta Biol Hung (2005) 1.05
Characteristics of nanobacteria and their possible role in stone formation. Urol Res (2003) 1.05
Studies on tetragonal lysozyme crystal growth rates. Acta Crystallogr D Biol Crystallogr (1994) 1.00
Lithogenesis: induction of renal calcifications by nanobacteria. Urol Res (2006) 0.98
A potential cause for kidney stone formation during space flights: enhanced growth of nanobacteria in microgravity. Kidney Int (2005) 0.95
Incorporation of microcrystals by growing protein and virus crystals. Proteins (1996) 0.90
The role of nanobacteria in urologic disease. World J Urol (2006) 0.90
Are apatite nanoparticles safe? Lancet (2007) 0.90
Possible association between nanobacteria and malignant microcalcifications in breast cancer. Breast J (2006) 0.89
Simulating micrometre-scale crystal growth from solution. Nature (2005) 0.88
Resolving the nanoparticles paradox. Nanomedicine (Lond) (2006) 0.87
Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro. Int J Pharm (2007) 0.82
Light-induced replication of nanobacteria: a preliminary report. J Clin Laser Med Surg (2002) 0.80
One size fits all? Australian regulation of nanoparticle exposure in the workplace. J Law Med (2007) 0.77